Professor Galina Velikova

|

Professor Velikova is a Consultant in Medical Oncology and
a Professor at the University of Leeds. Her clinical
work focuses on the systemic treatment of
breast cancer patients with early and advanced disease, including
chemotherapy, endocrine therapy and targeted treatments.

Professor Velikova leads the quality of
life sub-studies of national and international clinical
trials in breast cancer, including TACT2 and
SUPREMO. Nationally, she is the academic lead of
the NHS Quality of Life metric
initiative, aiming to implement routine quality of
life measurement for cancer patients and survivors after treatment
as a tool to drive care quality improvements.

Professor Velikova has a number
of national and international leadership
roles. She is past chair the British
Psychosocial Oncology Society (BPOS) and the European Organisation
for Research and Treatment of Cancer (EORTC) Quality of Life Group
in addition to being the past president of the International
Society for Quality of Life Research. Prof Velikova currently
chairs the National Cancer Research Institute (NCRI) Psychosocial
Oncology and Survivorship Clinical Studies Group. She is an elected
Board member the European Organisation for Research and Treatment
of Cancer (EORTC).